The innovative ORENgE x ElectroShade allows users to operate the shades (and potentially other accessories) with self-powering ORENgE printed semiconductor films. The energy generated by the film can ...
Hosted on MSN2d
How to choose the best shutters or blinds for your homeIf you are looking for an alternative to curtains to dress your windows, then read our guide on how to choose the best ...
Nightingale Awards Best Of Innovation Winner Answers Call For Chain-free Window Shade For Healthcare
Standard Textile, Altex's Newton chain-free window shade earns Best of Innovation Award winner in Healthcare Design's ...
The first-ever PDU designed solely for motorized shades, one Reaktor powers 3x the number of others, simplifying the ...
Automation allows homeowners to schedule their shades to adjust throughout the day, optimizing energy efficiency. “Imagine ...
Hosted on MSN17d
Curate daylight with Lutron’s automated shadesHoneycomb shades and horizontal sheer blinds ... Combined with Ketra recessed downlights, the motorized shades allow the designer to manipulate the quality of light to suit her purposes.
Swiss IoT module maker u-blox is to phase out its loss-making cellular IoT business, the firm has said. The division has over 200 employees; jobs are expected to go with its closure. It made revenue ...
Two new “pioneering” open-access scale-up facilities focused on advancing cellular agriculture are at the centre of a €12.5m investment grant from the Dutch National Growth Fund for Cellular ...
J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders
(AP Photo/Ted Shaffrey, File) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central ...
Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will ...
Johnson & Johnson is in talks to acquire Intra-Cellular Therapies Inc., a biopharmaceutical company focused on treatments for central nervous system disorders, people familiar with the matter said. A ...
(RTTNews) - Johnson & Johnson (JNJ) and Intra-Cellular Therapies, Inc. (ITCI) announced Monday that they have entered into a definitive agreement under which Johnson & Johnson will acquire all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback